Epigenetic therapy shows promise for endocrine-resistant breast cancer in mice

Endocrine resistance—a major cause of breast cancer deaths—can be underpinned by an epigenetic change called DNA methylation, researchers at the Garvan Institute of Medical Research have discovered. The team successfully reversed this methylation to reduce cancer growth in patient-derived animal models.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart